Shares of Nova Ltd. (NASDAQ:NVMI – Get Free Report) have received an average rating of “Moderate Buy” from the six research firms that are covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price target among brokers that have covered the stock in the last year is $227.80.
A number of equities analysts have recently weighed in on NVMI shares. Needham & Company LLC reaffirmed a “hold” rating on shares of Nova in a research note on Friday, November 8th. Benchmark raised their price objective on shares of Nova from $240.00 to $245.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Finally, Citigroup downgraded shares of Nova from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $273.00 to $224.00 in a research report on Monday, September 16th.
Get Our Latest Stock Analysis on NVMI
Hedge Funds Weigh In On Nova
Nova Stock Down 1.2 %
Shares of Nova stock opened at $172.39 on Friday. Nova has a 12 month low of $123.44 and a 12 month high of $247.21. The stock has a market cap of $5.01 billion, a PE ratio of 32.16, a price-to-earnings-growth ratio of 1.66 and a beta of 1.47. The business has a fifty day simple moving average of $192.84 and a 200-day simple moving average of $208.31.
About Nova
Nova Ltd. designs, develops, produces, and sells process control systems used in the manufacture of semiconductors in Israel, Taiwan, the United States, China, Korea, and internationally. Its product portfolio includes a set of metrology platforms for dimensional, films, and materials and chemical metrology measurements for process control for various semiconductor manufacturing process steps, including lithography, etch, chemical mechanical planarization, deposition, electrochemical plating, and advanced packaging.
Further Reading
- Five stocks we like better than Nova
- P/E Ratio Calculation: How to Assess Stocks
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Pros And Cons Of Monthly Dividend Stocks
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Earnings Per Share Calculator: How to Calculate EPS
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Nova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nova and related companies with MarketBeat.com's FREE daily email newsletter.